Media Pack
News

Current Edition

Volume 6 Issue 3

Upcoming Events

Advertisement

 
 
Volume 4 Issue 4

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis...
9 December 2021 Volume 4 Issue 4 Aristea Therapeutics | biopharma
Continue Reading →
news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...
29 June 2018 news alvogen | announce
Continue Reading →
news

Alpha Biopharma announces series A financing

 AZD3759, AlphaBio's lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor r...
22 June 2018 news Alpha | Announces
Continue Reading →
news

Wize Pharma signs distribution agreement in China for LO2A

HPGC is a division of Harbin Pharmaceutical Group Co. Ltd., one of China's largest healthcare companies with 20,000 employees and assets worth $2.9 billion. Wize P...
8 June 2018 news biopharma | Harbin
Continue Reading →
news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the...
1 June 2018 news Astellas | biopharma
Continue Reading →
Biopharma Group
A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (...
31 May 2018 A-D biopharma | Biotech
Continue Reading →
news

8,000 biopharma job opportunities if Ireland has the ambition

NIBRT CEO Dominic Carolan on stage at BioPharma Ambition 2018. Image: Luke Maxwell Ireland is at the forefro...
21 May 2018 news ambition | biopharma
Continue Reading →
news

For Expensive New Drugs, Biopharma Should Make Money-Back Guarantees Mandatory

In a recent paper on “Value-Based Pricing for Drugs”, authors Anna Kaltenboeck and Peter B. Bach of the Memorial Sloan Kettering Cancer Center discuss the high cost o...
3 May 2018 news biopharma | Drugs
Continue Reading →
news

Chinese biopharma firm to create 400 jobs in Dundalk

WuXi Biologics will invest €325m in company’s first site outside of China Taoiseach Leo Varadkar at the announcement of...
1 May 2018 news biopharma | chinese
Continue Reading →
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte